ArticleFrontiers in medicine2026
Quantitative CT features for COPD classification and GOLD spirometric severity assessment: a single-center model-development study.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic obstructive pulmonary disease (COPD) is diagnosed primarily by post-bronchodilator spirometry, but quantitative CT can characterize emphysema and visible-airway structural abnormalities that are not fully captured by airflow measurements alone. Because CT-derived emphysema and airway features have been extensively studied, this single-center study aimed to develop and describe quantitative CT-based classification models and to explore bronchial-tree morphology as a hypothesis-generating imaging phenotype, rather than to establish a clinically validated diagnostic replacement for pulmonary function testing. Methods: We enrolled 229 participants (138 with COPD and 91 control participants) at Fudan University Zhongshan Hospital. HRCT was used to quantify visible-airway dimensions at a prespecified eighth-generation airway, emphysema extent quantified as low attenuation area percentage (LAA%), and bronchial-tree morphology. Clinical variables including smoking history, modified Medical Research Council (mMRC) dyspnea score, and pulmonary function tests were recorded. Multivariable logistic regression was used to develop single-center models for COPD classification and for classification of severe airflow obstruction (FEV1%pred < 50%, corresponding to GOLD spirometric grades 3-4). Model performance is reported as apparent performance because internal and external validation were not performed. Results: Compared with control participants, COPD participants had smaller airway lumen area, higher wall-to-diameter ratio (T/D), higher wall area percentage (WA%), and higher LAA%. Mean wall thickness did not differ significantly, indicating that the group difference mainly reflected lumen narrowing rather than wall thickening. Emphysema extent was associated with lower FEV1/FVC and FEV1%pred. Sparse-type bronchial morphology was associated with COPD in multivariable analysis (OR 28.6, 95% CI 6.7-149.8), but the wide confidence interval and the need for reproducible operational validation require cautious interpretation. The combined clinical-CT development models achieved apparent AUCs of 0.906 for COPD classification and 0.859 for classification of severe airflow obstruction. Conclusion: Quantitative HRCT emphysema and visible-airway measurements were associated with COPD status and spirometric airflow obstruction. The models should be regarded as single-center development models, and the bronchial-tree morphology finding should be interpreted as hypothesis-generating until reproducibility, calibration, incremental value, and external validation are demonstrated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.